Index. Surg Oncol Clin N Am 15 (2006) Note: Page numbers of article titles are in boldface type.

Size: px

Start display at page:

Download "Index. Surg Oncol Clin N Am 15 (2006) Note: Page numbers of article titles are in boldface type."

Godfrey Gregory
5 years ago
Views:

1 Surg Oncol Clin N Am 15 (2006) Index Note: Page numbers of article titles are in boldface type. A Ablative therapy, for liver metastases in patients with neuroendocrine tumors, 517 with radioiodine in well-differentiated thyroid cancer, Adjuvant therapy, follow liver surgery in gastroenteropancreatic neuroendocrine tumors, 528 Adrenocortical carcinoma, clinical presentation, diagnosis, genetics, histopathology, treatment, adjuvant radiation, 549 cytotoxic therapy, endocrine therapy, surgery, Alcohol injection, of liver metastases in patients with neuroendocrine tumors, 518 Anaplastic thyroid carcinoma, diagnosis, 663 epidemiology and demographics, 662 management, molecular pathogenesis, novel therapeutics, outcome, role of radiation and chemotherapy, 665 role of surgery, Appendiceal carcinoid tumors, , 472 C Calcitonin measurement, in medullary thyroid carcinoma, Carcinoid heart disease, 473 Carcinoid syndrome, Carcinoid tumors, background, carcinoid heart disease, 473 carcinoid syndrome, diagnosis, imaging tests, laboratory tests, metastatic, management of, substances secreted by, 474 surgical treatment of primary, tumors by organ site of origin, Chemoembolization, hepatic arterial, for Chemotherapy, for malignant pheochromocytoma, 567 of gastroenteropancreatic neuroendocrine tumors, Cinacalcet hydrochloride (Sensipar), role of, for unresectable in parathyroid cancer, Colonic carcinoid tumors, 467, 472 Cushing s syndrome, adrenocortical carcinoma in patients with, 36 Cytotoxic therapy, for adrenocortical carcinoma, B Biochemical markers, of malignant pheochromocytoma, Biotherapy, for liver metastases in patients with neuroendocrine tumors, E Endocrine therapy, for adrenocortical carcinoma, F Familial gastrinoma. See Gastrinoma /06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi: /s (06) surgonc.theclinics.com

2 682 INDEX Follicular carcinoma, of thyroid gland, diagnosis, follow-up, outcome, postoperative management, treatment, G Gastric carcinoid tumors, , 471 Gastrinoma, sporadic and familial, imaging and localization of, medical management of primary, pathology, pathophysiology, and clinical diagnosis, surgical management of primary, treatment of metastatic, Gastroenteropancreatic neuroendocrine tumors, treatment of metastatic disease in patients with, ablative therapy for liver metastases, 517 adjuvant therapy following liver surgery, 528 alcohol injection of liver metastases, 518 biotherapy, chemotherapy, future systemic therapy, highly selective hepatic arterial chemoembolization, peptide receptor radionuclide therapy, staging and extent of, surgical treatment, vascular occlusive strategies, 518 Genetics, in adrenocortical carcinoma, in malignant pheochromocytoma, Glucagonoma, H Hepatic arterial chemoembolization, for Hiatopathology, of adrenocortical carcinoma, Histopathology, of malignant pheochromocytoma, Hu rthle cell carcinoma, of thyroid gland, diagnosis, follow-up, outcome, postoperative management, treatment, Hypercalcemic crisis, in parathyroid cancer, I Imaging, in parathyroid cancer, of adrenocortical carcinoma, of carcinoid tumors, of gastinomas, Insulinoma, diagnosis, medical therapy, 504 preoperative localization, symptoms, 501 treatment, Intraoperative parathyroid hormone assay, in parathyroid cancer, Intraoperative radio-guided localization, in parathyroid cancer, 578 Iodine, radioactive, for treatment of well-differentiated thyroid cancer, ablation with radioiodine, effect on outcome, false-positive scintiscans, 633 for distant metastases, 631 iodide accumulation in thyroid cells, mechanisms of, recombinant human thyroid-stimulating hormone for testing and treatment, 634 role for diagnostic scan with radioiodine, role for posttherapy scintiscan, side effects and complications of, thyroid stunning, 633 treatment of iodine (scan) negative thyroglobulin positive patients, 633

3 INDEX 683 L Liver transplantation, for metastatic neuroendocrine tumors, 507 Lymphoma, thyroid, diagnosis, epidemiology and risk factors, 668 outcome, 672 pathogenesis, role of chemoradiation, 672 staging and survival, 671 treatment, M Medullary thyroid carcinoma, calcitonin measurement, clinical features, diagnostic tests, epidemiology and classification, pathology and molecular oncogenesis, prognosis and natural history, RET genetic testing, treatment, Metastasis, to the thyroid, Metastatic disease, treatment of, in patients with neuroendocrine tumors, ablative therapy for liver metastases, 517 adjuvant therapy following liver surgery, 528 alcohol injection of liver metastases, 518 biotherapy, chemotherapy, future systemic therapy, highly selective hepatic arterial chemoembolization, liver transplantation for, 507 peptide receptor radionuclide therapy, staging and extent of, surgical treatment, vascular occlusive strategies, 518 with carcinoid tumors, role of octreotide, with gastrinoma, Molecular markers, of malignant pheochromocytoma, Molecular oncogenesis, of medullary thyroid carcinoma, Multiple endocrine neoplasia (MEN), in Zollinger-Ellison syndrome (gastrinoma), 481, N Neuroendocrine tumors, adrenocortical carcinoma, carcinoid tumors, gastrinoma, sporadic and familial, malignant pheochromocytoma, metastatic disease in patients with, of pancreas (excluding gastrinoma), other than gastrinoma, glucagonoma, insulinoma, liver transplantation for metastatic, 507 pancreatic polypeptide producing tumors, 507 somatostatinoma, 506 parathyroid cancer, thyroid malignancies, anaplastic thyroid carcinoma, follicular and Hürthle cell carcinoma, medullary thyroid cancer, metastasis to thyroid, papillary thyroid cancer, radioactive iodine in treatment of well-differentiated, thyroid lymphoma, O Octreotide, for metastatic carcinoid tumors, P Pancreatic neuroendocrine tumors (PNETs), gastrinoma, sporadic and familial, other than gastrinoma, glucagonoma, insulinoma, liver transplantation for metastatic, 507 pancreatic polypeptide producing tumors, 507 somatostatinoma, 506

4 684 INDEX Papillary thyroid cancer, diagnosis, imaging, long-term follow-up, new developments, pathology, prognosis, treatment, Parathyroid cancer, hypercalcemic crisis in, treatment of, imaging, intraoperative parathyroid hormone assay, intraoperative radio-guided localization, 578 presentation and diagnosis, role of cinacalcet hydrochloride (Sensipar) for unresectable disease, Parathyroid hormone assay, intraoperative, in parathyroid cancer, Peptide receptor radionuclide therapy, for neuroendocrine tumors, Pheochromocytoma, malignant, clinical evaluation, genetic predisposition, incidence and prevalence, 556 medical treatment, chemotherapy, 567 radiopharmaceutical therapy, molecular markers of, patient outcome and treatment options, surgical treatment, Polypeptide producing tumors, pancreatic, 507 Pulmonary carcinoid tumors, 465, 471 R Radiation therapy, adjuvant, for adrenocortical carcinoma, 549 Radio-guided localization, intraoperative, in parathyroid cancer, 578 Radioactive iodine, for treatment of well-differentiated thyroid cancer, ablation with radioiodine, effect on outcome, false-positive scintiscans, 633 for distant metastases, 631 iodide accumulation in thyroid cells, mechanisms of, recombinant human thyroidstimulating hormone for testing and treatment, 634 role for diagnostic scan with radioiodine, role for posttherapy scintiscan, side effects and complications of, thyroid stunning, 633 treatment of iodine (scan) negative thyroglobulin positive patients, 633 Radiopharmaceutical therapy, for malignant pheochromocytoma, Rectal carcinoid tumors, 467, 472 RET gene, in medullary thyroid carcinoma, genetic testing for, S Scintiscans, false-positive, in well-differentiated thyroid cancer, 633 posttherapy, in well-differentiated thyroid cancer, Sensipar. See Cinacalcet hydrochloride. Small intestinal carcinoid tumors, 466, 471 Somatostatinoma, 506 Sporadic gastrinoma. See Gastrinoma. Stunning, thyroid, 633 T Thyroglobulin positive patients, iodine (scan) negative, treatment of, Thyroid malignancies, anaplastic thyroid carcinoma,

5 INDEX 685 follicular and Hürthle cell carcinoma, medullary thyroid cancer, metastasis to thyroid, papillary thyroid cancer, radioactive iodine in treatment of well-differentiated, thyroid lymphoma, Thyroid stunning, 633 V Vascular occlusive strategies, for liver metastases in patients with Z Zollinger-Ellison syndrome. See Gastrinoma.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic